Christian Marinaccio, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chorioallantoic Membrane | 5 | 2017 | 50 | 1.300 |
Why?
|
| Microvessels | 5 | 2017 | 572 | 1.210 |
Why?
|
| Tryptases | 3 | 2016 | 177 | 0.930 |
Why?
|
| Primary Myelofibrosis | 5 | 2022 | 210 | 0.760 |
Why?
|
| Neovascularization, Physiologic | 3 | 2015 | 1336 | 0.620 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 600 | 0.580 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2015 | 1400 | 0.540 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 1056 | 0.540 |
Why?
|
| GATA1 Transcription Factor | 3 | 2022 | 296 | 0.470 |
Why?
|
| Mast Cells | 4 | 2016 | 1428 | 0.460 |
Why?
|
| Myeloproliferative Disorders | 4 | 2022 | 610 | 0.460 |
Why?
|
| Ki-67 Antigen | 1 | 2015 | 631 | 0.430 |
Why?
|
| Neovascularization, Pathologic | 5 | 2017 | 2635 | 0.430 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 282 | 0.430 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2023 | 3605 | 0.430 |
Why?
|
| Pathology | 1 | 2015 | 270 | 0.410 |
Why?
|
| Microscopy | 1 | 2015 | 880 | 0.340 |
Why?
|
| Megakaryocytes | 5 | 2022 | 566 | 0.320 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2015 | 2048 | 0.280 |
Why?
|
| Hodgkin Disease | 1 | 2014 | 1381 | 0.270 |
Why?
|
| Antigens, CD | 1 | 2014 | 4000 | 0.230 |
Why?
|
| Chick Embryo | 5 | 2017 | 980 | 0.200 |
Why?
|
| Software | 1 | 2015 | 4421 | 0.180 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2020 | 131 | 0.170 |
Why?
|
| Heart | 1 | 2013 | 4390 | 0.170 |
Why?
|
| Janus Kinase 2 | 2 | 2019 | 541 | 0.160 |
Why?
|
| F-Box Proteins | 1 | 2020 | 202 | 0.160 |
Why?
|
| STAT5 Transcription Factor | 1 | 2019 | 264 | 0.160 |
Why?
|
| Thrombocythemia, Essential | 1 | 2019 | 107 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10181 | 0.150 |
Why?
|
| Bone Marrow | 5 | 2022 | 2918 | 0.150 |
Why?
|
| Calreticulin | 1 | 2018 | 115 | 0.140 |
Why?
|
| Vidarabine | 1 | 2018 | 336 | 0.140 |
Why?
|
| Liver | 1 | 2013 | 7514 | 0.140 |
Why?
|
| Melanoma | 1 | 2015 | 5692 | 0.140 |
Why?
|
| Phthalazines | 1 | 2018 | 377 | 0.130 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2016 | 88 | 0.130 |
Why?
|
| Thrombopoiesis | 1 | 2017 | 164 | 0.120 |
Why?
|
| Aquatic Organisms | 1 | 2015 | 42 | 0.120 |
Why?
|
| Fractals | 1 | 2015 | 128 | 0.120 |
Why?
|
| Leukemia | 1 | 2023 | 1511 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2014 | 3478 | 0.120 |
Why?
|
| Mastocytosis, Systemic | 1 | 2015 | 102 | 0.110 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2015 | 166 | 0.110 |
Why?
|
| Mutation | 4 | 2023 | 29877 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2018 | 2925 | 0.110 |
Why?
|
| Mitosis | 1 | 2018 | 1195 | 0.110 |
Why?
|
| Endometrium | 1 | 2016 | 404 | 0.110 |
Why?
|
| Animals | 16 | 2023 | 167838 | 0.110 |
Why?
|
| Cytokines | 2 | 2022 | 7346 | 0.110 |
Why?
|
| Chickens | 1 | 2015 | 858 | 0.100 |
Why?
|
| Superior Colliculi | 1 | 2013 | 98 | 0.100 |
Why?
|
| Angiopoietin-1 | 1 | 2013 | 123 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 542 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2015 | 740 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2824 | 0.090 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 590 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2023 | 4491 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 1395 | 0.090 |
Why?
|
| Cell Separation | 1 | 2016 | 1724 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 2804 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2014 | 547 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2448 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2017 | 2920 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1889 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2014 | 772 | 0.080 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 884 | 0.080 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1388 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5793 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5214 | 0.080 |
Why?
|
| Apoptosis | 3 | 2018 | 9492 | 0.070 |
Why?
|
| Disease Progression | 2 | 2022 | 13479 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 21981 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1627 | 0.070 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 1361 | 0.070 |
Why?
|
| Mice | 7 | 2022 | 81138 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3390 | 0.060 |
Why?
|
| Biological Products | 1 | 2015 | 914 | 0.060 |
Why?
|
| Particulate Matter | 1 | 2017 | 2557 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11058 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 8929 | 0.060 |
Why?
|
| Fibrosis | 2 | 2022 | 2041 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3489 | 0.060 |
Why?
|
| Spheroids, Cellular | 2 | 2016 | 329 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 58867 | 0.050 |
Why?
|
| Oxygen | 1 | 2015 | 4188 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2015 | 80121 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2017 | 2841 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2018 | 1408 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18110 | 0.050 |
Why?
|
| Humans | 19 | 2023 | 759255 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 3810 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 3600 | 0.050 |
Why?
|
| Chromatin | 2 | 2023 | 2939 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2022 | 372 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 168617 | 0.050 |
Why?
|
| Middle Aged | 6 | 2019 | 219653 | 0.040 |
Why?
|
| Myocardium | 1 | 2013 | 4680 | 0.040 |
Why?
|
| Adult | 6 | 2019 | 219390 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 13621 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3190 | 0.040 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2019 | 53 | 0.040 |
Why?
|
| Female | 10 | 2019 | 390240 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5730 | 0.040 |
Why?
|
| Transcription Factor Brn-3A | 1 | 2018 | 13 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3482 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2022 | 1132 | 0.040 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2019 | 104 | 0.040 |
Why?
|
| Polyploidy | 1 | 2018 | 119 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10440 | 0.040 |
Why?
|
| Male | 7 | 2019 | 358719 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2019 | 12774 | 0.040 |
Why?
|
| G1 Phase | 1 | 2018 | 403 | 0.040 |
Why?
|
| Nitro Compounds | 1 | 2017 | 74 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 5131 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9590 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9374 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16871 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20031 | 0.030 |
Why?
|
| Dystroglycans | 1 | 2016 | 62 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2016 | 88 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2017 | 385 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2016 | 144 | 0.030 |
Why?
|
| Aquaporin 4 | 1 | 2016 | 159 | 0.030 |
Why?
|
| Dystrophin | 1 | 2016 | 284 | 0.030 |
Why?
|
| Carcinogens | 1 | 2017 | 449 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7593 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2017 | 360 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1836 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 550 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 13946 | 0.030 |
Why?
|
| Binding Sites | 1 | 2023 | 6053 | 0.030 |
Why?
|
| Point Mutation | 1 | 2019 | 1594 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 191 | 0.030 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 221 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1695 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22019 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2667 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2018 | 2218 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1886 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 717 | 0.030 |
Why?
|
| Spleen | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.030 |
Why?
|
| Metals | 1 | 2017 | 731 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 1387 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 730 | 0.020 |
Why?
|
| Quinazolines | 1 | 2018 | 1362 | 0.020 |
Why?
|
| Cell Count | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2474 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1066 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2016 | 838 | 0.020 |
Why?
|
| Protein Binding | 1 | 2023 | 9334 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2016 | 1152 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3584 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11476 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1314 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3537 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5039 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23362 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6131 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5789 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5783 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9528 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15636 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12800 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12964 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3333 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18968 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21988 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11123 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7851 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8491 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8953 | 0.010 |
Why?
|